
1. j gen virol. 2012 dec;93(pt 12):2646-2651. doi: 10.1099/vir.0.045146-0. epub 2012
sep 19.

hyperediting human t-cell leukemia virus type 2 simian t-cell leukemia
virus type 3 dsrna adenosine deaminase adar-1.

ko nl(1), birlouez e(2), wain-hobson s(2), mahieux r(3)(1), vartanian jp(2).

author information: 
(1)epidemiology physiopathology oncogenic viruses, institut pasteur, cnrs 
ura 3015, 28 rue du dr roux, 75724 paris cedex 15, france.
(2)molecular retrovirology unit, institut pasteur, cnrs ura 3015, 28 rue du dr
roux, 75724 paris cedex 15, france.
(3)retroviral oncogenesis, u758 human virology, ens lyon, ums3444/us8 biosciences
gerland-lyon sud, 46 allée d'italie, 69007 lyon, france.

rna editing mediated adenosine deaminases acting rna (adars) converts
adenosine (a) inosine (i) residues dsrna templates. adar-1-mediated
editing essentially described rna viruses, present work addresses the
issue two δ-retroviruses, human t-cell leukemia virus type 2 simian
t-cell leukemia virus type 3 (htlv-2 stlv-3). examined whether adar-1
could edit htlv-2 stlv-3 virus genomes cell culture vivo. using a
highly sensitive pcr-based method, referred 3di-pcr, showed adar-1 
could hypermutate adenosine residues htlv-2. stlv-3 hypermutation obtained
without using 3di-pcr, suggesting higher mutation frequency virus.
detailed analysis dinucleotide editing context showed preferences 5'
ara 5' ura. conclusion, present observations demonstrate adar-1
massively edits htlv-2 stlv-3 retroviruses vitro, probably remains a
rare phenomenon vivo.

doi: 10.1099/vir.0.045146-0 
pmcid: pmc4091295
pmid: 22993189  [indexed medline]

